Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001808:Blood Vessels / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000473:pathology* / Q000517:prevention & control*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000473:pathology / Q000517:prevention & control; D010879:Piperazines / Q000627:therapeutic use*; D011407:Propane / Q000627:therapeutic use; D012510:Sarcoma 180 / Q000188:drug therapy; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D010879:Piperazines; D003520:Cyclophosphamide; D011407:Propane